Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    - The institution name was updated from UT Southwestern Medical Center to University of Texas Southwestern Medical Center.
    Difference
    0.1%
    Check dated 2025-12-30T08:41:12.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Locations information was added (including Texas) and the page was updated to revision v3.3.3, while the Texas Locations entry and the HHS Vulnerability Disclosure were removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:43:56.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:50.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The notice about potential delays in updates due to a lapse in government funding was removed. This reduces visibility into the page's current operating status and data currency.
    Difference
    0.4%
    Check dated 2025-11-17T17:46:12.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The new screenshot shows minor cosmetic/layout changes to the page; no study data or eligibility criteria changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T12:29:23.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.
    Difference
    2%
    Check dated 2025-10-05T16:43:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.